Cardiac mapping is a technique in which the information from cardiac electrograms is gathered and displayed. Cardiac mapping is used to diagnose the heart rhythms especially in case of arrhythmia. The cardiac mapping procedure is usually done by inserting catheter into the heart chamber percutaneously and recording the electrograms sequentially, this is done in order to correlate the electrograms with cardiac anatomy. The new 3D cardiac mapping systems create the three dimensional model of any chamber of heart and can track exact location of the catheter. This allows movement of the catheters without using X-ray. They are designed to improve the resolution and gain prompt cardiac activation maps.
The 3D cardiac mapping system market is anticipated to grow with a significant CAGR owing to the increase in number of patients with arrhythmia and other cardiac disorders, rising pressure to reduce diagnosis errors and increasing healthcare expenditure. The major factors driving the growth of 3D cardiac mapping systems is the precision and patient safety enabled by real-time monitoring. The increase in aging population who are more prone to chronic heart disorders will elevate the demand for the 3D cardiac mapping system. The increase in prevalence and diagnosis rate of cardiac illness is the major factors which is creating the demand for 3D cardiac mapping systems. The 3D cardiac mapping also help in reducing the time of diagnosis. The restraining factors for the 3D cardiac mapping system market are high cost of services and limited adoption rate of the systems.
North America contributes maximum share to the 3D cardiac mapping system market. European countries are expected to represent significant growth rates due to the growing healthcare practices. Amongst the Asian countries, India and China are more promising due to large population pool, increased prevalence of cardiac diseases, increasing awareness, rapid improvement in healthcare services with the saturation in the developed markets.
In 2018, the global 3D Cardiac Mapping System market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global 3D Cardiac Mapping System status, future forecast, growth opportunity, key market and key players. The study objectives are to present the 3D Cardiac Mapping System development in United States, Europe and China.
The key players covered in this study
St. Jude Medical
Boston Scientific Corporation
Market segment by Type, the product can be split into
Basket Catheter Mapping
Real-Time Positional Management (Cardiac Pathways) EP System
Market segment by Application, split into
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global 3D Cardiac Mapping System status, future forecast, growth opportunity, key market and key players.
To present the 3D Cardiac Mapping System development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of 3D Cardiac Mapping System are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.